AR038224A1 - Empleo de alquilfosfocolinas en el tratamiento preventivo de enfermedades causadas por protozoarios - Google Patents

Empleo de alquilfosfocolinas en el tratamiento preventivo de enfermedades causadas por protozoarios

Info

Publication number
AR038224A1
AR038224A1 ARP030100214A ARP030100214A AR038224A1 AR 038224 A1 AR038224 A1 AR 038224A1 AR P030100214 A ARP030100214 A AR P030100214A AR P030100214 A ARP030100214 A AR P030100214A AR 038224 A1 AR038224 A1 AR 038224A1
Authority
AR
Argentina
Prior art keywords
preventive treatment
diseases caused
protozoarios
alquilfosfocolinas
employment
Prior art date
Application number
ARP030100214A
Other languages
English (en)
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of AR038224A1 publication Critical patent/AR038224A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones farmacéuticas que contienen alquilfosfocolinas, en particualr la hexadecilfosfocolina o, en su caso, fosfato de octadecil-(1,1-dimetil-piperidinio-4-ilo) para el tratamiento preventivo de enfermedades causadas por protozoarios, en particular la leishmaniasis. Esquema de dosificación de las mencionadas composiciones para el tratamiento preventivo de las mencionadas enfermedades.
ARP030100214A 2002-01-25 2003-01-24 Empleo de alquilfosfocolinas en el tratamiento preventivo de enfermedades causadas por protozoarios AR038224A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10203195A DE10203195A1 (de) 2002-01-25 2002-01-25 Verwendung von Alkylphosphocholinen in der Präventivbehandlung von Protozoenerkrankungen

Publications (1)

Publication Number Publication Date
AR038224A1 true AR038224A1 (es) 2005-01-05

Family

ID=7713213

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100214A AR038224A1 (es) 2002-01-25 2003-01-24 Empleo de alquilfosfocolinas en el tratamiento preventivo de enfermedades causadas por protozoarios

Country Status (16)

Country Link
EP (1) EP1467742A1 (es)
JP (1) JP2005515244A (es)
CN (1) CN1622811A (es)
AR (1) AR038224A1 (es)
AU (1) AU2003236787B2 (es)
BR (1) BR0307021A (es)
CA (1) CA2470185A1 (es)
CO (1) CO5601024A2 (es)
DE (1) DE10203195A1 (es)
IL (2) IL162492A0 (es)
MX (1) MXPA04007193A (es)
NZ (1) NZ548040A (es)
PE (1) PE20030732A1 (es)
TW (1) TWI339582B (es)
WO (1) WO2003061669A1 (es)
ZA (1) ZA200404690B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT501545B1 (de) * 2005-02-23 2007-10-15 Obwaller Andreas Dr Reinigungsmittel für kontaktlinsen
PL1962862T3 (pl) * 2005-12-19 2014-01-31 Aeterna Zentaris Gmbh Pochodne alkilofosfolipidów o ograniczonej cytotoksyczności i ich zastosowania
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
CN104473941A (zh) * 2014-12-20 2015-04-01 长沙佰顺生物科技有限公司 一种含有米替福新的药物制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132345A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Ether-lysolecithine und alkylphosphocholine in liposomen
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
EP0634927B1 (en) * 1992-03-06 2001-07-04 Lica Pharmaceuticals A/S Treatment and prophylaxis of diseases caused by parasites, or bacteria
HUP0004363A3 (en) * 1998-01-22 2002-12-28 Zentaris Gmbh Solid pharmaceutical compositions containing miltefosine for use in the treatment of leishmaniasis
DE10020812C2 (de) * 2000-04-20 2003-06-26 Robert Koch Inst Verwendung von Naphthindazol-4,9-chinonen als Antiparasitika
AU2002232400A1 (en) * 2000-11-06 2002-05-15 U.S. Army Medical Research And Materiel Command Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis

Also Published As

Publication number Publication date
TWI339582B (en) 2011-04-01
DE10203195A1 (de) 2003-08-07
IL162492A0 (en) 2005-11-20
CN1622811A (zh) 2005-06-01
CA2470185A1 (en) 2003-07-31
AU2003236787B2 (en) 2007-03-22
NZ548040A (en) 2007-06-29
IL162492A (en) 2009-12-24
JP2005515244A (ja) 2005-05-26
PE20030732A1 (es) 2003-09-27
BR0307021A (pt) 2004-11-03
WO2003061669A1 (de) 2003-07-31
EP1467742A1 (de) 2004-10-20
CO5601024A2 (es) 2006-01-31
MXPA04007193A (es) 2004-10-29
TW200302103A (en) 2003-08-01
ZA200404690B (en) 2004-09-27

Similar Documents

Publication Publication Date Title
GT200500007A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia.
ATE417610T1 (de) Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen
CL2004000969A1 (es) Compuestos derivados de alquilarilo; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento y/o profilaxis de la obesidad y trastornos relacionados.
ECSP034732A (es) Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias
ES2115237T3 (es) Fenil heterociclos como inhibidores de la ciclooxigenasa-2.
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
BR0206381A (pt) Derivados do ácido fumárico como inibidor de nf-kappab
UY28215A1 (es) Quinazolinas utiles como moduladores de canales iónicos
DK1465626T3 (da) Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
UY24354A1 (es) Composiciones farmacéuticas que contienen epinastina
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
ES2183937T3 (es) Inhibidores de la adhesion celular.
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
ES2153076T3 (es) Agentes herbicidas basados en bencisoxazol y bencisotiazol sustituidos.
UY29790A1 (es) Sales de diariloimidazola-4-carboxamidas, composiciones que las contienen, procesos de preparación y aplicaciones
HN2002000110A (es) Uso de (z) - 2 - ciano - 3 - hidroxi - butil - 2 - acido enoico (4' - trifluorometil fenilo) - amida para el tratamiento de la esclerosis multiple.
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
HRP20041013B1 (hr) Formulacija visoke doze ibandronata
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
GT199900081A (es) Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos.
AR038224A1 (es) Empleo de alquilfosfocolinas en el tratamiento preventivo de enfermedades causadas por protozoarios
BR0315055A (pt) Diamidas de ácido pirimidin-4,6-dicarboxìilco para a inibição seletiva de colagenases
ES2153875T3 (es) Agentes antitromboticos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure